J. Bodegård

J. Erikssen, D. Thelle, J. Bodegård, 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Reasons for terminating an exercise test provide independent prognostic information: 2014 apparently healthy men followed for 26 years.

K. Liestøl, J. Erikssen, J. Bodegård, 2005, European heart journal.

Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study

A. Bollmann, N. Tangri, M. Vervloet, 2022, The Lancet regional health. Europe.

Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality.

J. Eriksson, J. Bodegård, M. Thuresson, 2016, Diabetes research and clinical practice.

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study

K. Khunti, M. Jørgensen, K. Birkeland, 2018, Diabetes, obesity & metabolism.

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice Results from the CVD-REAL study

K. Khunti, M. Jørgensen, K. Birkeland, 2018 .

Cardiovascular Events in Subgroups of Patients During Primary Treatment of Hypertension With Candesartan or Losartan

S. Kjeldsen, J. Bodegård, D. Russell, 2011, Journal of clinical hypertension.

Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries

N. Tangri, A. Maggioni, T. Kadowaki, 2022, Diabetes, obesity & metabolism.

Risk factor management of type 2 diabetic patients in primary care in the Scandinavian countries between 2003 and 2015.

P. Nilsson, M. Jørgensen, K. Birkeland, 2020, Primary care diabetes.

Rapidly upsloping ST-segment on exercise ECG: a marker of reduced coronary heart disease mortality risk

K. Liestøl, S. Kjeldsen, J. Erikssen, 2013, European journal of preventive cardiology.

Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study

K. Birkeland, J. Eriksson, J. Bodegård, 2021, Diabetes Care.

Cross-sectional and longitudinal analyses of the association between lung function and exercise capacity in healthy Norwegian men

C. Janson, J. Erikssen, K. Stavem, 2018, BMC Pulmonary Medicine.

The Oslo Ischaemia Study: cohort profile

K. Liestøl, S. Kjeldsen, J. Erikssen, 2021, BMJ Open.

Dapagliflozin Compared to DPP-4 inhibitors is Associated with Lower Risk of Cardiovascular Events and All-cause Mortality in Type 2 Diabetes Patients (CVD-REAL Nordic): a multinational observational study.

B. Carstensen, M. Jørgensen, K. Birkeland, 2017 .

Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6–10

J. Eriksson, J. Bodegård, M. Thuresson, 2018, Diabetes Care.

Hospitalization for Heart Failure and Death in New Users of SGLT-2 Inhibitors in Patients With and Without Cardiovascular Disease—CVD Real Study

K. Khunti, M. Jørgensen, K. Birkeland, 2017 .

Second-line treatment with sulfonylurea compared to DPP4 inhibitors demonstrated associations with earlier treatment intensification with insulin

J. Eriksson, J. Bodegård, M. Thuresson, 2015 .

Dapagliflozin Is Associated With Lower Risk Of Hospitalization For Kidney Disease, Heart Failure And All Cause Death Compared To DPP-4i: CVD-REAL Nordic

K. Birkeland, J. Eriksson, J. Bodegård, 2017 .

Possible angina detected by the WHO angina questionnaire in apparently healthy men with a normal exercise ECG: coronary heart disease or not? A 26 year follow up study

J. Erikssen, D. Thelle, J. Bodegård, 2004, Heart.

Exercise systolic blood pressure at moderate workload predicts cardiovascular disease and mortality through 35 years of follow-up in healthy, middle-aged men

K. Liestøl, S. Kjeldsen, J. Erikssen, 2017, Blood pressure.

Seven-Year Increase in Exercise Systolic Blood Pressure at Moderate Workload Predicts Long-Term Risk of Coronary Heart Disease and Mortality in Healthy Middle-Aged Men

K. Liestøl, S. Kjeldsen, J. Erikssen, 2013, Hypertension.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Upper Normal Blood Pressures Predict Incident Atrial Fibrillation in Healthy Middle-Aged Men: A 35-Year Follow-Up Study

K. Liestøl, S. Kjeldsen, J. Erikssen, 2012, Hypertension.

Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data

J. Eriksson, J. Bodegård, M. Thuresson, 2022, Cardiovascular Diabetology.

Implementation of the Convention on Biological Diversity

J. Bodegård, 1997 .

Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden)

G. Fonarow, M. Vaduganathan, A. Coats, 2021, European journal of heart failure.

Triglycerides-diabetes association in healthy middle-aged men: modified by physical fitness? A long term follow-up of 1962 Norwegian men in the Oslo Ischemia Study.

K. Liestøl, S. Kjeldsen, J. Erikssen, 2013, Diabetes research and clinical practice.

Fasting Serum Triglycerides Predict New Onset Diabetes in Healthy Middle-Aged Men A 35-year follow-up of a Norwegian cohort Running title : Triglycerides Predict New Onset Diabetes

K. Liestøl, S. Kjeldsen, J. Erikssen, 2011 .

Low‐grade systolic murmurs in healthy middle‐aged individuals: innocent or clinically significant? A 35‐year follow‐up study of 2014 Norwegian men

K. Liestøl, S. Kjeldsen, J. Erikssen, 2012, Journal of internal medicine.

Health-care costs of losartan and candesartan in the primary treatment of hypertension

L. Levin, S. Kjeldsen, J. Bodegård, 2010, Journal of Human Hypertension.

Fasting blood glucose is independently associated with resting and exercise blood pressures and development of elevated blood pressure

S. Kjeldsen, J. Erikssen, J. Bodegård, 2003, Journal of hypertension.

Temporal Reduction in Chronotropic Index Predicts Risk of Cardiovascular Death Among Healthy Middle‐Aged Men: a 28‐Year Follow‐Up Study

K. Liestøl, S. Kjeldsen, J. Erikssen, 2016, Journal of the American Heart Association.

Early Versus Late Morning Measurement of Blood Pressure in Healthy Men. A Potential Source of Measurement Bias?

S. Kjeldsen, J. Erikssen, L. Sandvik, 2002, Blood pressure.

Low‐dose acetylsalicylic acid and gastrointestinal ulcers or bleeding – a cohort study of the effects of proton pump inhibitor use patterns

J. Sundström, J. Oldgren, J. Bodegård, 2013, Journal of internal medicine.

Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study.

J. Shaw, N. Tangri, C. Chiang, 2020, The lancet. Diabetes & endocrinology.

Heart rate reserve predicts cardiovascular death among physically unfit but otherwise healthy middle-aged men: a 35-year follow-up study

K. Liestøl, S. Kjeldsen, J. Erikssen, 2016, European journal of preventive cardiology.

middle-aged men : a 35-year follow-up study Heart rate reserve predicts cardiovascular death among physically unfit but otherwise healthy

K. Liestøl, S. Kjeldsen, J. Erikssen, 2014 .

Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study

K. Khunti, M. Jørgensen, K. Birkeland, 2017 .

Lower heart failure and chronic kidney disease risks associated with sodium‐glucose cotransporter‐2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases

I. Komuro, T. Kadowaki, T. Yajima, 2021, Diabetes, obesity & metabolism.

Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study

A. Banerjee, I. Komuro, T. Kadowaki, 2020, Diabetes, obesity & metabolism.

Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34 009 primary care patients

P. Nilsson, J. Sundström, B. Svennblad, 2013, Journal of hypertension.

Long-term predictors of stroke in healthy middle-aged men

K. Liestøl, S. Kjeldsen, J. Erikssen, 2018, International journal of stroke : official journal of the International Stroke Society.

Effects of interactive patient smartphone support app on drug adherence and lifestyle changes in myocardial infarction patients: A randomized study.

Joakim Alfredsson, J. Alfredsson, C. Varenhorst, 2016, American heart journal.

Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study

P. Nilsson, J. Sundström, B. Svennblad, 2015, Cardiovascular Diabetology.

Exercise Systolic Blood Pressure at Moderate Workload Is Linearly Associated With Coronary Disease Risk in Healthy Men.

K. Liestøl, S. Kjeldsen, J. Erikssen, 2019, Hypertension.

SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL.

K. Khunti, M. Jørgensen, K. Birkeland, 2018, Journal of the American College of Cardiology.

Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study

J. Bodegård, A. Carlborg, M. Thuresson, 2015, Bipolar disorders.

Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting

I. Holme, S. Kjeldsen, J. Sundström, 2015, Clinical Drug Investigation.

History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case–control study

J. Bodegård, M. Thuresson, V. Ritsinger, 2023, BMJ Open.

Prevalence, outcomes and costs of a contemporary, multinational population with heart failure

A. Bollmann, N. Tangri, J. Sundström, 2023, Heart.

Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF).

L. Lund, B. Bozkurt, G. Savarese, 2022, JACC. Heart failure.

Novel insights into stroke risk beyond resting and maximal bicycle exercise systolic blood pressure

K. Liestøl, S. Kjeldsen, J. Erikssen, 2021, Journal of hypertension.

Weight change patterns and healthcare costs in patients with newly-diagnosed type-2 diabetes in Sweden.

P. Nilsson, B. Svennblad, M. Ekman, 2017, Primary care diabetes.

Healthcare utilization and costs following newly diagnosed type-2 diabetes in Sweden: A follow-up of 38,956 patients in a clinical practice setting.

J. Sundström, B. Svennblad, J. Bodegård, 2015, Primary care diabetes.

Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension

S. Kjeldsen, J. Bodegård, J. Stålhammar, 2009, Journal of Human Hypertension.

Characteristics of bipolar disorder patients treated with immediate- and extended-release quetiapine in a real clinical setting: a longitudinal, cohort study of 1761 patients

J. Bodegård, A. Carlborg, M. Thuresson, 2015, Therapeutic advances in psychopharmacology.

Exercise testing of healthy men in a new perspective: from diagnosis to prognosis.

K. Liestøl, J. Erikssen, D. Thelle, 2004, European heart journal.

Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HF.

L. Lund, J. Cleland, B. Bozkurt, 2023, JACC. Heart failure.

Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

K. Khunti, N. Tangri, J. Eriksson, 2021, Cardiovascular Diabetology.

Interaction between inflammation and blood viscosity predicts cardiovascular mortality

S. Kjeldsen, J. Erikssen, L. Sandvik, 2010 .